92 related articles for article (PubMed ID: 36197776)
21. Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Abubakar M; Köbel M; Rodriguez M; Sar A
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):91-98. PubMed ID: 34799503
[TBL] [Abstract][Full Text] [Related]
22. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
23. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
24. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
Pirog EC
Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686
[TBL] [Abstract][Full Text] [Related]
25. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
26. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
[TBL] [Abstract][Full Text] [Related]
29. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
Tao X; Zheng B; Yin F; Zeng Z; Li Z; Griffith CC; Luo B; Ding X; Zhou X; Zhao C
Am J Clin Pathol; 2017 May; 147(5):477-483. PubMed ID: 28340235
[TBL] [Abstract][Full Text] [Related]
30. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
[TBL] [Abstract][Full Text] [Related]
31. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
33. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
Chen W; Molijn A; Enqi W; Zhang X; Jenkins D; Yu X; Quint W; Schmidt JE; Li J; Pirog E; Liu B; Li Q; Liu X; Li L; Qiao Y;
Int J Cancer; 2016 Dec; 139(12):2687-2697. PubMed ID: 27554015
[TBL] [Abstract][Full Text] [Related]
34. Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme.
Pulkkinen J; Kares S; Huhtala H; Kholová I
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943636
[TBL] [Abstract][Full Text] [Related]
35. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
36. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization.
Duggan MA; Benoit JL; McGregor SE; Nation JG; Inoue M; Stuart GC
Hum Pathol; 1993 Feb; 24(2):121-5. PubMed ID: 8381762
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
39. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
[TBL] [Abstract][Full Text] [Related]
40. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
